Tylicki, 133 patient vitamin D prophylaxis study: 14% lower mortality [p=0.61] https://c19p.org/tylicki
copied to clipboard
Predictors of Mortality in Hemodialyzed Patients after SARS-CoV-2 Infection
et al., Journal of Clinical Medicine, doi:10.3390/jcm11020285
Retrospective 133 COVID+ hemodialysis patients in Poland, showing lower mortality with existing vitamin D use, without statistical significance.
|
risk of death, 14.4% lower, RR 0.86, p = 0.61, treatment 28 of 85 (32.9%), control 25 of 48 (52.1%), NNT 5.2, adjusted per study, odds ratio converted to relative risk, multivariable.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Tylicki et al., 6 Jan 2022, retrospective, Poland, peer-reviewed, 10 authors, study period 6 October, 2020 - 28 February, 2021, dosage not specified.
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.